908 Devices (NASDAQ:MASS) Director Sells $52,039.68 in Stock

908 Devices Inc. (NASDAQ:MASS) Director Christopher Brown sold 7,392 shares of the company’s stock in a transaction that occurred on Thursday, April 9th. The stock was sold at an average price of $7.04, for a total transaction of $52,039.68. Following the completion of the transaction, the director owned 963,137 shares in the company, valued at approximately $6,780,484.48. This represents a 0.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Stock Performance

Shares of NASDAQ MASS opened at $7.14 on Monday. The firm’s 50 day moving average price is $6.47 and its 200-day moving average price is $6.66. The company has a market cap of $266.89 million, a PE ratio of 12.98 and a beta of 0.54. 908 Devices Inc. has a 52-week low of $3.79 and a 52-week high of $9.34.

908 Devices (NASDAQ:MASS) last issued its earnings results on Tuesday, March 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.01. The firm had revenue of $17.38 million for the quarter, compared to the consensus estimate of $16.19 million. 908 Devices had a net margin of 34.68% and a negative return on equity of 14.99%. On average, analysts forecast that 908 Devices Inc. will post -1.99 earnings per share for the current fiscal year.

Key Headlines Impacting 908 Devices

Here are the key news stories impacting 908 Devices this week:

• Neutral Sentiment: SVP Kevin J. McCallion sold 18,580 shares on April 8 at an average $7.05 (proceeds $130,989). The sale was executed under a Rule 10b5‑1 plan and left him with 44,925 shares. Form 4
• Neutral Sentiment: SVP Kevin J. McCallion sold an additional 5,420 shares on April 9 at an average $7.03 (proceeds ~$38.1k), also under a 10b5‑1 plan. He still holds 44,925 shares. Form 4
• Neutral Sentiment: Director Christopher D. Brown sold 17,578 shares on April 10 at $7.07 (proceeds ~$124.3k), under a 10b5‑1 plan; he remains a large holder (~945,559 shares). Form 4
• Neutral Sentiment: Director Christopher D. Brown sold 7,392 shares on April 9 at $7.04 (proceeds ~$52.0k), and 15,030 shares on April 8 at $7.05 (proceeds ~$106.0k); all under a 10b5‑1 plan. Form 4
• Neutral Sentiment: Reported short interest shows 0 shares (as of April 10), implying no measurable short pressure; the short‑interest ratio is effectively 0.0 days based on average volume. Source data flagged anomalous/NaN changes.
• Negative Sentiment: Combined impact: insiders sold ~64,000 shares this week for roughly $450k in proceeds. Even though sales were via 10b5‑1 plans (which mutes informational content), the concentrated volume of insider selling can create near‑term downward pressure or raise investor questions about insider liquidity needs.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC bought a new position in 908 Devices during the third quarter valued at approximately $28,000. Raymond James Financial Inc. bought a new position in 908 Devices in the second quarter worth approximately $48,000. Daiwa Securities Group Inc. bought a new position in 908 Devices in the second quarter worth approximately $61,000. PCM Encore LLC bought a new position in 908 Devices in the fourth quarter worth approximately $62,000. Finally, The Manufacturers Life Insurance Company bought a new position in 908 Devices in the second quarter worth approximately $77,000. Institutional investors own 88.06% of the company’s stock.

Analysts Set New Price Targets

MASS has been the topic of a number of research analyst reports. Wall Street Zen upgraded shares of 908 Devices from a “hold” rating to a “buy” rating in a research report on Saturday, March 14th. Weiss Ratings restated a “sell (d-)” rating on shares of 908 Devices in a research report on Wednesday, January 21st. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $12.00.

908 Devices Company Profile

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations.